Country: Malaysia
Language: English
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
FACTOR IX COMPLEX
GRIFOLS MALAYSIA SDN. BHD.
FACTOR IX COMPLEX
20ml mL
Grifols Biologicals LLC
Alphanine ® SD DESCRIPTION Coagulation Factor IX (Human), AlphaNine ® SD, is a purified, solvent detergent treated, virus filtered preparation of Factor IX derived from human plasma. 1 It contains a minimum of 150 IU Factor IX/mg protein; levels of Factor VII (proconvertin), Factor II (prothrombin) and Factor X (Stuart-Prower Factor) which are below the limit of detection (less than 0.04 Factor VII unit, less than 0.05 Factor II unit, and less than 0.05 Factor X unit per IU Factor IX). AlphaNine ® SD is a sterile, lyophilized preparation intended for intravenous administration only. Each vial is a single dose container. AlphaNine ® SD contains not more than (NMT) 0.04 unit of heparin, NMT 0.2 mg of dextrose, NMT 1.0 μg polysorbate 80 and NMT 0.10 μg tri(n-butyl) phosphate/IU of Factor IX. CLINICAL PHARMACOLOGY AlphaNine ® SD is a purified formulation of Factor IX containing not less than 150 IU Factor IX activity/mg of total protein. 2 AlphaNine ® SD contains non-therapeutic levels of Factor II, Factor VII and Factor X. Thrombogenicity of AlphaNine ® SD in animals is markedly lower than that of Factor IX Complex, Profilnine ® Heat-Treated. Five lots of AlphaNine ® SD (three lots of non-virus filtered product and two lots of virus filtered product) failed to show any evidence of thrombogenicity when tested directly in the Wessler rabbit stasis model for thrombogenicity 3-6 at a dose of 200 IU Factor IX/kg body weight. When various lots of AlphaNine ® SD were further tested at doses between 300 and 650 IU Factor IX/kg, only 5 out of 40 animals (12.5%) showed evidence of thrombus formation (Wessler scores of +1, +2, +1, +1, +1 out of +4 maximum). In comparison, Factor IX Complex concentrate, Profilnine ® , was thrombogenic in 100% of the animals tested at a dose of 100 IU Factor IX/kg. At a dose of 200 IU Factor IX/kg body weight in a porcine model, the heptane heat-treated formulation of this product (AlphaNine ® ) showed little evidence of disseminated intravascular coagulation (DIC) following infusi Read the complete document